Efficacy of denosumab in steroid-induced osteoporosis against insufficient effect by bisphosphonate.

Efficacy of denosumab in steroid-induced osteoporosis against insufficient effect by bisphosphonate. - Efficacy of denosumab in steroid-induced osteoporosis against insufficient effect by bisphosphonate.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040533

Enrollment

Registered

2020-05-26

Start date

2017-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Steroid induced osteoporosis uncontrolled bisphosphonate

Exclusion criteria

Exclusion criteria: Can not use denosumab Can not agree this trial

Design outcomes

Primary

Measure	Time frame
The changes in bone mineral density (BMD) and bone turnover markers were investigated at 24 and 52 weeks.	—

Countries

Japan

Contacts

Public ContactNpbpru Kitamura

Nihon University School of Medicine Division of Hematology and Rheumatology Department of Medicine

kitamura.noboru@nihon-u.ac.jp03-3972-8111

Outcome results